Onureg
Term · Oncology and biomedicine · MLC-T-ONC-006086
A drug that contains the active ingredient azacitidine and is used to treat adults with certain types of acute myeloid leukemia. It is used in patients whose cancer is in first complete remission after intensive induction chemotherapy and who were not able to finish intensive therapy that would cure their cancer. Onureg stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite.
| Identifier | MLC-T-ONC-006086 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-006086",
"term": "Onureg",
"field": "Oncology and biomedicine",
"definition": "A drug that contains the active ingredient azacitidine and is used to treat adults with certain types of acute myeloid leukemia. It is used in patients whose cancer is in first complete remission after intensive induction chemotherapy and who were not able to finish intensive therapy that would cure their cancer. Onureg stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/onureg/"
}
Record 12,244 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.